Dual burden of chronic physical diseases and anxiety/mood disorders among Sao Paulo Megacity Mental Health Survey Sample, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
ASKARI, Melanie S.
FILHO, Alexandre Chiavegatto
VIANA, Maria Carmen
MARTINS, Silvia S.
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.220, p.1-7, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: We assessed comorbid associations of 12-month DSM-IV mood/any anxiety disorders with chronic physical conditions within the Sao Paulo (SP) Megacity Mental Health cross-sectional survey of 5037 participants and explored whether strength of comorbid associations were modified when controlling for demographics. Methods: Chi-square tests and logistic regressions were used to examine comorbid associations of DSM-IV mood/anxiety disorders as measured by the WHO Composite International Diagnostic Interview (CIDI 3.0), and self-reported chronic physical conditions among adults from the SP Megacity Mental Health Survey. Results: Among those with any mood or anxiety disorder, chronic pain disorder was the most common physical condition (48.9% and 44.9%, respectively). Significant unadjusted odds ratios (OR) of comorbidity were found between diagnosis of two or more physical conditions and any mood disorders (3.08, 95% CI: 2.27-4.17), and any anxiety disorders (2.49, 95% CI: 1.95-3.17). Comorbidities remained significant when stratified by gender and controlling for marital status, household income, and education (latter two only included within anxiety models). Limitations: These results cannot be generalized to other cities or rural populations. Homeless and institutionalized populations were not surveyed. Due to cross-sectional study design, the direction of association between chronic disease/chronic disease risk factors and mood disorders is unclear. Conclusions: Dual burden of chronic physical conditions and mood/anxiety disorders is a notable problem among the Sao Paulo Megacity Survey population, with enhanced comorbidity experienced by community members with multiple physical conditions. Clinicians should consider these findings in understanding healthcare delivery for individuals suffering from both psychiatric disorders and chronic physical conditions.
Palavras-chave
Comorbidity, Mood disorder, Anxiety disorder, Chronic condition
Referências
  1. Andrade LH, 2013, CLINICS, V68, P1392, DOI 10.6061/clinics/2013(11)02
  2. Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879
  3. Barry Danielle, 2009, PSYCHIAT TIMES
  4. Brumpton B, 2013, INT J OBESITY, V37, P1268, DOI 10.1038/ijo.2012.204
  5. Campanha AM, 2015, PHARMACOEPIDEM DR S, V24, P1207, DOI 10.1002/pds.3826
  6. Collaborators G., 2016, LANCET, V388
  7. Consortium T. W. W., 2004, JAMA-J AM MED ASSOC, V291, P2581
  8. de Groot M, 2001, PSYCHOSOM MED, V63, P619
  9. Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022
  10. Faith MS, 2002, J PSYCHOSOM RES, V53, P935, DOI 10.1016/S0022-3999(02)00308-2
  11. Filho Alexandre Dias Porto Chiavegatto, 2013, J EPIDEMIOL COMMUNIT
  12. Fullerton C, 2000, REV MED CHILE, V128, P729
  13. Gili M, 2010, GEN HOSP PSYCHIAT, V32, P240, DOI 10.1016/j.genhosppsych.2010.01.013
  14. Glassman AH, 1998, AM J PSYCHIAT, V155, P4
  15. Istica I. B. d. G. e. E., 2001, IBGE CENSO DEMOGRAFI
  16. Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
  17. Kim JH, 2016, PSYCHIAT INVEST, V13, P496, DOI 10.4306/pi.2016.13.5.496
  18. Luppino Floriana, 2010, ARCH GEN PSYCHIAT, V67
  19. Martinez N. T., 2016, REV COLOMB PSIQUI S1, V1, pS141
  20. Minayo M. C. d. S., 2012, CAD SAUDE PUBLICA
  21. Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
  22. National Center for Chronic Disease Prevention and Health Promotion, 2016, PREV CHRON DIS EL LE
  23. Noorbala AA, 2017, ARCH IRAN MED, V20, P128, DOI 0172003/AIM.003
  24. ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741
  25. Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107
  26. Paykel ES, 2000, PSYCHOL MED, V30, P269, DOI 10.1017/S003329179900183X
  27. Kessler Ronald C., 2002, NEUROPSYCHOPHARMACOL, V67
  28. Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
  29. Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006
  30. Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292
  31. Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824
  32. Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5
  33. Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016
  34. Wang Y. P., 2016, EPIDEMIOL PSYCHIAT S, V12, P1
  35. Watch H. W. s. H., 2008, ANXIETY PHYS ILLNESS
  36. WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
  37. World Health Organization, 2004, BURD DIS DALYS
  38. World Health Organization, 2012, WHO STAT PROF
  39. World Health Organization, 2005, CHRON DIS HLTH PRO 2
  40. World Health Organization (WHO), 2015, BMI CLASSIFICATION
  41. World Health Organization, 2010, WORLD HLTH STAT HLTH
  42. Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616